Viewing Study NCT07104032


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-01-02 @ 2:20 AM
Study NCT ID: NCT07104032
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-11-21
First Post: 2025-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
Sponsor: Ono Pharmaceutical Co. Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module